Immutep Ltd (IMMP)
3.14
-0.09
(-2.79%)
USD |
NASDAQ |
May 22, 16:00
3.14
0.00 (0.00%)
After-Hours: 20:00
Immutep Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 21, 2024 | 313.93M |
| May 20, 2024 | 298.48M |
| May 17, 2024 | 281.83M |
| May 16, 2024 | 277.08M |
| May 15, 2024 | 265.19M |
| May 14, 2024 | 278.27M |
| May 13, 2024 | 278.27M |
| May 10, 2024 | 272.32M |
| May 09, 2024 | 287.78M |
| May 08, 2024 | 285.40M |
| May 07, 2024 | 277.08M |
| May 06, 2024 | 286.59M |
| May 03, 2024 | 265.19M |
| May 02, 2024 | 249.73M |
| May 01, 2024 | 239.03M |
| April 30, 2024 | 249.73M |
| April 29, 2024 | 247.36M |
| April 26, 2024 | 244.98M |
| April 25, 2024 | 239.03M |
| April 24, 2024 | 237.85M |
| April 23, 2024 | 228.33M |
| April 22, 2024 | 205.75M |
| April 19, 2024 | 197.42M |
| April 18, 2024 | 191.48M |
| April 17, 2024 | 198.61M |
| Date | Value |
|---|---|
| April 16, 2024 | 198.61M |
| April 15, 2024 | 204.56M |
| April 12, 2024 | 225.96M |
| April 11, 2024 | 230.71M |
| April 10, 2024 | 230.71M |
| April 09, 2024 | 247.36M |
| April 08, 2024 | 260.43M |
| April 05, 2024 | 262.81M |
| April 04, 2024 | 258.06M |
| April 03, 2024 | 229.52M |
| April 02, 2024 | 231.90M |
| April 01, 2024 | 221.20M |
| March 28, 2024 | 206.94M |
| March 27, 2024 | 214.07M |
| March 26, 2024 | 214.07M |
| March 25, 2024 | 227.15M |
| March 22, 2024 | 223.58M |
| March 21, 2024 | 228.33M |
| March 20, 2024 | 220.01M |
| March 19, 2024 | 217.64M |
| March 18, 2024 | 217.64M |
| March 15, 2024 | 214.07M |
| March 14, 2024 | 229.52M |
| March 13, 2024 | 240.22M |
| March 12, 2024 | 233.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
17.85M
Minimum
Apr 03 2020
322.25M
Maximum
Nov 05 2021
137.17M
Average
135.39M
Median
Enterprise Value Benchmarks
| Kazia Therapeutics Ltd | 5.246M |
| Opthea Ltd | 123.80M |
| Alterity Therapeutics Ltd | -- |
| Mesoblast Ltd | -- |
| Immuron Ltd | 2.087M |